je.st
news
Tag: merck
Merck Receives 2016 ENERGY STAR Sustained Excellence Award From U.S. Environmental Protection Agency
2016-04-01 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Company Receives EPA Honor for 11th Consecutive Year KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it has received an ENERGY STAR 2016 Partner of the Year Sustained Excellence Award from the U.S. Environmental Protection Agency (EPA) for its continued improvement of energy performance and leadership in energy management in both the pharmaceutical and industrial sectors. Language: English Contact: Media:Claire Gillespie, 267-305-0932orInvestors:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: star
protection
energy
agency
Merck to Present New Findings from Chronic Hepatitis C Clinical Development Programs at The International Liver CongressTM 2016
2016-03-30 13:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Presentations Include Results from Phase 3 Study Evaluating ZEPATIER (elbasvir and grazoprevir) Compared to Sofosbuvir-Containing Regimen, and Results from Studies in Difficult-to-Treat Populations KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the planned presentations of data from the companys broad chronic hepatitis C virus (HCV) clinical development programs at the upcoming International Liver Congress 2016. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Sarra Herzog, 908-740-1871orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: international
development
present
programs
Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
2016-03-25 15:53:27| Biotech - Topix.net
The damages award is far less than the $2 billion Merck had demanded. On Tuesday, the same jury in San Jose, California, upheld the validity of the patents, which lie at the heart of the dispute over Gilead's blockbuster drugs Sovaldi and Harvoni.
Tags: pay
million
drug
ordered
Merck Foundation Awards Grant to American Cancer Society for Program to Improve Access to High-Quality Cancer Care in Underserved Communities
2016-03-24 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. $1.58 Million Grant Supports Patient Navigation Program, Empowering Patients and Caregivers with Information and Support KENILWORTH, N.J.--(BUSINESS WIRE)--The Merck Foundation (the Foundation) and the American Cancer Society (ACS) announced today that the Foundation provided a grant of $1.58 million over four years to the ACS to implement a comprehensive Patient Navigation Program in three U.S. communities where substantial cancer care disparities exist. This funding will allow the ACS to enhance its already substantial Patient Navigation Program and expand its focus on access to high-quality care, patient empowerment and care coordination. Language: English Contact: Merck Media Contacts:Claire Gillespie, 267-305-0932Jeanine Clemente, 908-236-5059orMerck Investor Contacts:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879orAmerican Cancer Society Media Contact:Evelyn Barella, 810-610-5234orAmerican Cancer Society Investor Contact:Katherine Sharpe, 404-329-5705 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: program
access
care
american
Impact Of Merck Litigation On Ionis Pharmaceuticals
2016-03-24 10:32:22| Biotech - Topix.net
Ionis has the cash necessary to advance its pipeline, so it is not necessarily reliant upon a verdict with Gilead in order to meet targets. The much watched litigation between Gilead Sciences and Merck appears as though it is rapidly heading towards a jury verdict.
Tags: impact
litigation
pharmaceuticals
merck
Sites : [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] next »